Informed consent for blood transfusion: Should the possibility of prion risk be included?

Transfusion Medicine Reviews

Volumn 18, Issue 3, 2004, Pages 177-183

  Hart, Jason ^a   Leier, Brendan ^a   Nahirniak, Susan ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AWARENESS; BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT JAKOB DISEASE; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; DOCTOR PATIENT RELATION; HUMAN; INFORMED CONSENT; NONHUMAN; PRION; PRION DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 3242655623     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2004.03.001     Document Type: Article

References (39)

1. Prusiner S.B. Shattuck lecture - Neurodegenerative diseases and prions. N Engl J Med. 344:2001;1516-1526
2. Coulthart M.B., Cashman N.R. Variant Creutzfeldt-Jakob disease A summary of current scientific knowledge in relation to public health. Can Med Assoc J. 165:2001;51-58
3. Wilson K., Hebert P.C., Laupacis A., et al. A policy analysis of major decisions relating to Creutzfeldt-Jakob disease and blood supply. Can Med Assoc J. 165:2001;59-65
4. Blajchman M.A., Goldman M., Webert K.E., et al. Proceedings of a consensus conference The screening of blood donors for variant CJD. Transfus Med Rev. 18:2004;73-92
5. Brown P., Preece M., Brandel J.-P., et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology. 55:2000;1075-1081
6. Evatt B., Austin H., Barnhart E., et al. Surveillance for Creutzfeldt-Jakob disease among persons with hemophilia. Transfusion. 38:1998;817-820
7. Holman R.C., Khan A.S., Belay E.D., et al. Creutzfeldt-Jakob disease in the United States, 1979-1994 Using national mortality data to assess the possible occurrence of variant cases. Emerg Infect Dis. 2:1996;333-337
8. Wilson K., Code C., Ricketts M.N. Risk of acquiring Creutzfeldt-Jakob disease from blood transfusions Systemic review of case-control studies. Br Med J. 321:2000;17-19
9. UK Government Department of Health Web site on CJD/BSE. 2003;. Available at: www.doh.gov.uk/cjd. Accessed November 19
10. Jansen G.H., Voll C.L., Robinson C.A., et al. First case of variant Creutzfeldt-Jakob disease in Canada. Can Commun Dis Rep. 29:2003;117-120
11. Hilton D.A., Fathers E., Edwards P., et al. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet. 352:1998;703-704
12. Hill A.F., Butterworth R.J., Joiner S., et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet. 353:1999;183-189
13. Cashman N.R., Loertscher R., Nalbantoglu J., et al. Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell. 61:1990;185-192
14. Hunter N., Foster J., Chong A., et al. Transmission of prion diseases by blood transfusion. J Gen Virol. 83:2002;2897-2905
15. World Federation of Hemophilia Statement on Transmission of vCJD by Transfusion. 2003;. Available at: www.wfh.org. Accessed December 19
16. Malette v Schulman. 1990;. 67 DLR 94th) (Ont CA) at p 338
17. Reibl v Hughes. 1980;. 2 SCR 880
18. Suls J., Wan C.K. Effects of sensory and procedural information on coping with stressful medical procedures and pain A meta-analysis. J Consult Clin Psychol. 57:1989;372-379
19. Etchells E., Sharpe G., Burgess M.M., et al. Bioethics for clinicians 2. Disclosure. Can Med Assoc J. 155:1996;387-391
20. Downey J., Caulfield T. Canadian Health Law and Policy. 1999;117-141 Butterworths Canada Limited
21. King S.M., Watson H., Heurter H., et al. Notifying patients exposed to blood products associated with Creutzfeldt-Jakob disease Theoretical risk for real people. Can Med Assoc J. 159:1998;771-775
22. Larke B. The quandary of Creutzfeldt-Jakob disease. Can Med Assoc J. 159:1998;789-792
23. Sibbald Barbara. Blood recipients and CJD To notify or not to notify, that is the question. Can Med Assoc J. 159:1998;829-831
24. Meyer Estate v Rogers. 1991;. 78 DLR (4th) 307 (Ont. Gen. Div.)
25. Powell D., Leiss W. Mad Cows or Crazy Communications? Mad Cows and Mother's Milk The Perils of Poor Risk Communication. 1997;11 McGill-Queen's University Press
26. Powell D., Leiss W. Mad Cows or Crazy Communications? Mad Cows and Mother's Milk The Perils of Poor Risk Communication. 1997;6 McGill-Queen's University Press
27. Slovic P. Perceived risk, trust, and democracy. Risk Analysis. 13:1993;675-682
28. Slovic P., Flynn J., Johnson S., et al. The Dynamics of Trust in Situations of Risk. Decision Research Report 93-2, Decision Research Incorporated. 1993
29. Opinion of Professions in Britain. 2003;. Available at: http://www.mori.com/polls/trends/trust.shtml. December 3
30. Davis J.A., Smith T.W. Annual Series. General Social Surveys, Cumulative Codebook ICPSR Study #3764 Section D, Question d321.Annual Series. 2002;University of Chicago, National Opinion Research Center, Chicago, IL
31. How Canadians Perceive Various Professions. 2003;. Available at: http://www.nwtrna.com/news/trusted_pros.pdf. Accessed February 20
32. Goodnough L.T., Brecher M.E., Kanter M.H., et al. Blood transfusion. N Engl J Med. 340:1999;438-447
33. Petrides M. Adverse effects of transfusion. Petrides M., Stack G. Practical Guide to Transfusion Medicine. 2001;117-150 AABB Press, Bethesda, MD
34. Popovsky M.A. Transfusion Reactions. (ed). :2001;AABB Press, Bethesda, MD
35. All About Blood. 2003;. Available at: http://www.aabb.org/ All_About_Blood/FAQs/aabb_faqs.htm. Accessed December 3
36. Capen K. There's more to Krever's report than the blood issue - Much more. Can Med Assoc J. 158:1998;92-94
37. Fienstone S.M., Kapikian A.Z., Purcel R.H., et al. Transfusion-associated hepatitis not due to viral hepatitis A or B. N Engl J Med. 292:1975;767-770
38. Choo Q.-L., Kuo G., Weiner A.J., et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-364
39. Llewelyn C.A., Hewitt P.E., Knight R.S.G., et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet. 363:2004;417-421